// App-Quantinova.ai

PB0878 : Longitudinal Analysis of rFVIIIFc Use and Efficacy in the UK: A Report from the National Haemophilia Database

Researchers

Presenter

  • C. Wall

Principal Investigators

  • M. Scott

  • H. Xiang

  • B. Palmer

  • P. Collins

  • P. Chowdary

  • G. Dolan

  • N. Curry

  • D. Allsup

  • C. Hay

  • D. Hart

Medical Centers

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • UK National Haemophilia Database, Manchester, United Kingdom

  • University Hospital of Wales, Cardiff, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Queens Centre for Oncology and Haematology, Castle Hill Hospital, Hull, United Kingdom

  • The Royal London Hospital Haemophilia Centre, Barts and the London School of Medicine and Dentistry, QMUL, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • Protein Tyrosine Phosphatase, Non-Receptor Type 11

Drug/Treatment

  • FVIIIFc

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved